Zu "215303-72-3" wurden 3 Artikel gefunden!

Für die Filterung wurden keine Ergebnisse gefunden!
RWJ-67657
RWJ-67657

Artikelnummer: TGM-T16812-100mg

Description: RWJ-67657 (JNJ 3026582) is an orally active, selective p38alpha and p38beta MAPK inhibitor (IC50s: 1 and 11 µM, respectively), with no activity at p38gamma and p38delta, and demonstrates cardioprotective effects. Target: p38 MAPK. Smiles: OCCC#Cc1nc(c(-c2ccncc2)n1CCCc1ccccc1)-c1ccc(F)cc1. References:...
Schlagworte: JNJ 3026582
Anwendung: p38 alpha inhibitor, p38 beta inhibitor
CAS 215303-72-3
MW: 425.5 D
ab 40,00 €
Bewerten
RWJ 67657
RWJ 67657

Artikelnummer: Cay18718-1

RWJ 67657 is an orally active inhibitor of the MAP kinases p38alpha and p38beta (IC50s = 1 and 11 µM, respectively, in vitro) that is inactive against p38gamma and p38delta, as well as several other kinases. It blocks the release of TNF-alpha and IL-1beta from peripheral blood mononuclear cells stimulated with LPS...
Schlagworte: JNJ-3026582, 4-[4-(4-fluorophenyl)-1-(3-phenylpropyl)-5-(4-pyridinyl)-1H-imidazol-2-yl]-3-butyn-1-ol
Anwendung: p38 alpha inhibitor, p38 beta inhibitor
CAS 215303-72-3
MW: 425.5 D
ab 61,00 €
Bewerten
RWJ-67657
RWJ-67657

Artikelnummer: SYN-1072-M001

Soluble in DMSO or ethanol. The cytokine Tumor necrosis factor-alpha (TNF-alpha) is secreted by activated monocytes/macrophages and T lymphocytes and has been implicated in several disease states, including rheumatoid arthritis, inflammatory bowel disease, septic shock, and osteoporosis. Monocyte/macrophage...
Schlagworte: RWJ67657
Anwendung: p38 inhibitor
CAS 215303-72-3
MW: 425,5 D
ab 77,00 €
Bewerten